Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia

BACKGROUND: Intimal hyperplasia remains the primary cause of vein graft failure for the 1 million yearly bypass procedures performed using human saphenous vein (HSV) grafts. This response to injury is caused in part by the harvest and preparation of the conduit. The use of Brilliant Blue FCF (FCF) r...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Vasc Surg
Huvudupphovsmän: Osgood, Michael J., Sexton, Kevin, Voskresensky, Igor, Hocking, Kyle, Song, Jun, Komalavilas, Padmini, Brophy, Colleen, Cheung-Flynn, Joyce
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5480606/
https://ncbi.nlm.nih.gov/pubmed/27763268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvs.2015.02.028
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk